Ionis' 2015 Financial Results Outperform Projections
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Ionis Pharma (IONS) Misses Q4 EPS Views
February 25, 2016 8:56 AM ESTIonis Pharma (NASDAQ: IONS) reported Q4 EPS of ($0.59), $0.11 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $51.6 million versus the consensus estimate of $49.32 million.
For earnings history and earnings-related data on Ionis Pharma (IONS) click here.
... More


